Clinical subtypes of breast cancer in Thai women: a population-based study of Chiang Mai province

[1]Stewart BW, Wild CP, editors. World Cancer Report 2014. IARC Press. 2014.StewartBWWildCPeditorsWorld Cancer Report 2014IARC Press2014Search in Google Scholar

[2]Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN: cancer incidence and mortality worldwide: IARC cancer base no. 11. International Agency for Research on Cancer. 2013.FerlayJSoerjomataramIErvikMDikshitREserSMathersCet alGLOBOCAN: cancer incidence and mortality worldwide: IARC cancer base no11. International Agency for Research on Cancer2013Search in Google Scholar

[3]Imsamran W, Chaiwerawattana A, Wiangnon S, Pongnikorn D, Suwanrungruang K, Sangrajrang S, et al. Cancer in Thailand Volume VIII, 2010–2012, National Cancer Institute, Ministry of Public Health; Bangkok, Thailand. 2015.ImsamranWChaiwerawattanaAWiangnonSPongnikornDSuwanrungruangKSangrajrangSet alCancer in Thailand Volume VIII, 2010–2012, National Cancer Institute, Ministry of Public Health; Bangkok, Thailand2015Search in Google Scholar

[4]Pongnikorn D, Daoprasert K, Waisri N, Laversanne M, Bray F. Cancer incidence in northern Thailand: results from six population-based cancer registries 1993–2012. Int J Cancer. 2018; 142:1767–75. doi:10.1002/ijc.31203.PongnikornDDaoprasertKWaisriNLaversanneMBrayFCancer incidence in northern Thailand: results from six population-based cancer registries 1993–2012Int J Cancer201814217677510.1002/ijc.3120329226335Open DOISearch in Google Scholar

[5]Sripan P, Sriplung H, Pongnikorn D, Virani S, Bilheem S, Chaisaengkhaum U, et al. Trends in female breast cancer by age group in the Chiang Mai population. Asian Pac J Cancer Prev. 2017; 18:1411–6. doi:10.22034/APJCP.2017.18.5.1411.SripanPSriplungHPongnikornDViraniSBilheemSChaisaengkhaumUet alTrends in female breast cancer by age group in the Chiang Mai populationAsian Pac J Cancer Prev2017181411610.22034/APJCP.2017.18.5.1411555555528612595Open DOISearch in Google Scholar

[6]Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med. 2014; 11:101–15. doi:10.7497/j.issn.2095-3941.2014.02.005.YouldenDRCrambSMYipCHBaadePDIncidence and mortality of female breast cancer in the Asia-Pacific regionCancer Biol Med2014111011510.7497/j.issn.2095-3941.2014.02.005406980525009752Open DOISearch in Google Scholar

[7]Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J, et al. Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomarkers Prev. 2012; 21: 1848–55. doi:10.1158/1055-9965.EPI-12-0474.HaqueRAhmedSAInzhakovaGShiJAvilaCPolikoffJet alImpact of breast cancer subtypes and treatment on survival: an analysis spanning two decadesCancer Epidemiol Biomarkers Prev20122118485510.1158/1055-9965.EPI-12-0474346733722989461Open DOISearch in Google Scholar

[8]Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007; 109:1721–8. doi:10.1002/cncr.22618.BauerKRBrownMCressRDPariseCACaggianoVDescriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer RegistryCancer20071091721810.1002/cncr.2261817387718Open DOISearch in Google Scholar

[9]Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014; 106. doi:10.1093/jnci/dju055.HowladerNAltekruseSFLiCIChenVWClarkeCARiesLAet alUS incidence of breast cancer subtypes defined by joint hormone receptor and HER2 statusJ Natl Cancer Inst201410610.1093/jnci/dju055458055224777111Open DOISearch in Google Scholar

[10]Chuthapisith S, Permsapaya W, Warnnissorn M, Akewanlop C, Sirivatanauksorn V, Prasarttong Osoth P. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev. 2012; 13:459–62.ChuthapisithSPermsapayaWWarnnissornMAkewanlopCSirivatanauksornVPrasarttongOsoth PBreast cancer subtypes identified by the ER, PR and HER-2 status in Thai womenAsian Pac J Cancer Prev2012134596210.7314/APJCP.2012.13.2.45922524806Search in Google Scholar

[11]Lertsanguansinchai P, Chottetanaprasith T, Chatamra K, Sampatanukul P, Wannakrairot P, Rojpornpradit P, et al. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2002; 85 Suppl 1:S193–202.LertsanguansinchaiPChottetanaprasithTChatamraKSampatanukulPWannakrairotPRojpornpraditPet alEstrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial HospitalJ Med Assoc Thai200285Suppl1S193202Search in Google Scholar

[12]Koonmee S, Sirithunyaporn S, Phanomsri E. Hormonal receptors status of breast cancer in northeastern Thai women: an analysis of 241 cases at Srinagarind Hospital. Srinagarind Med J. 2006; 21:343–51.KoonmeeSSirithunyapornSPhanomsriEHormonal receptors status of breast cancer in northeastern Thai women: an analysis of 241 cases at Srinagarind HospitalSrinagarind Med J20062134351Search in Google Scholar

[13]Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol. 2005; 23:7350–60.BrentonJDCareyLAAhmedAACaldasCMolecular classification and molecular forecasting of breast cancer: ready for clinical application?J Clin Oncol20052373506010.1200/JCO.2005.03.384516145060Search in Google Scholar

[14]Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008; 26:2373–8.NguyenPLTaghianAGKatzMSNiemierkoAAbiRaad RFBoonWLet alBreast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapyJ Clin Oncol2008262373810.1200/JCO.2007.14.428718413639Search in Google Scholar

[15]Virani S, Wetzel EC, Laohawiriyakamol S. Ethnic disparity in breast cancer survival in southern Thai women. Cancer Epidemiol. 2018; 54:82–9. doi:10.1016/j.canep.2018.02.007.ViraniSWetzelECLaohawiriyakamolSEthnic disparity in breast cancer survival in southern Thai womenCancer Epidemiol20185482910.1016/j.canep.2018.02.00729684800Open DOISearch in Google Scholar

[16]Glass AG, Lacey JV, Carreon JD, Hoover RN. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007; 99:1152–61. doi:10.1093/jnci/djn077.GlassAGLaceyJVCarreonJDHooverRNBreast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor statusJ Natl Cancer Inst20079911526110.1093/jnci/djn07718398103Open DOISearch in Google Scholar

[17]Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999; 91:2020–8.PorterPLEl-BastawissiAYMandelsonMTLinMGKhalidNWatneyEAet alBreast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancersJ Natl Cancer Inst1999912020810.1093/jnci/91.23.202010580027Search in Google Scholar

[18]Mukem S, Meng Q, Sriplung H, Tangcharoensathien V. Low coverage and disparities of breast and cervical cancer screening in Thai women: analysis of National Representative Household Surveys. Asian Pac J Cancer Prev. 2015; 16:8541–51.MukemSMengQSriplungHTangcharoensathienVLow coverage and disparities of breast and cervical cancer screening in Thai women: analysis of National Representative Household SurveysAsian Pac J Cancer Prev20151685415110.7314/APJCP.2015.16.18.854126745114Search in Google Scholar

[19]Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014; 5:412–24. doi:10.5306/wjco.v5.i3.412.YersalOBarutcaSBiological subtypes of breast cancer: prognostic and therapeutic implicationsWorld J Clin Oncol201454122410.5306/wjco.v5.i3.412412761225114856Open DOISearch in Google Scholar

[20]Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, et al. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer. 2011; 11:292. doi:10.1186/1471-2407-11-292.SuYZhengYZhengWGuKChenZLiGet alDistinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort studyBMC Cancer20111129210.1186/1471-2407-11-292315745821749714Open DOISearch in Google Scholar